# PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR PNEUMOCYSTIS

> **NIH NIH N01** · ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. · 2020 · $1,185,838

## Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

## Key facts

- **NIH application ID:** 10134161
- **Project number:** 272201500007I-P00005-27200007-1
- **Recipient organization:** ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
- **Principal Investigator:** KRISTOPHER PAOLINO
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,185,838
- **Award type:** —
- **Project period:** 2018-03-30 → 2023-01-25

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10134161

## Citation

> US National Institutes of Health, RePORTER application 10134161, PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR PNEUMOCYSTIS (272201500007I-P00005-27200007-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10134161. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*